Cardinal Health, Inc. (CAH) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
CAH Insider Trading Activity
CAH Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $22,078,021 | 10 | 100 |
Related Transactions
| Alt Aaron E | Chief Financial Officer | 0 | $0 | 1 | $252,998 | $-252,998 |
| Scherer Mary C. | Chief Accounting Officer | 0 | $0 | 1 | $432,919 | $-432,919 |
| Greene Michelle D. | Chief Information Officer | 0 | $0 | 1 | $435,400 | $-435,400 |
| Mayer Jessica L | Chief Legal/Compliance Officer | 0 | $0 | 2 | $3.72M | $-3.72M |
| Snow Ola M | Chief Human Resources Officer | 0 | $0 | 2 | $4.13M | $-4.13M |
| Mason Stephen M | CEO, GMPD Segment | 0 | $0 | 1 | $5.13M | $-5.13M |
| Hollar Jason M. | Chief Executive Officer | 0 | $0 | 2 | $7.97M | $-7.97M |
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Insider Activity of Cardinal Health, Inc.
Over the last 12 months, insiders at Cardinal Health, Inc. have bought $0 and sold $22.08M worth of Cardinal Health, Inc. stock.
On average, over the past 5 years, insiders at Cardinal Health, Inc. have bought $29,239 and sold $9.02M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $14,944 was made by Brennan Michelle (director) on 2022‑11‑15.
List of Insider Buy and Sell Transactions, Cardinal Health, Inc.
| 2024-11-14 | Sale | Scherer Mary C. | Chief Accounting Officer | 3,504 0.0015% | $123.55 | $432,919 | +5.31% | |
| 2024-08-21 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 16,573 0.0068% | $109.39 | $1.81M | +12.65% | |
| 2024-08-19 | Sale | Hollar Jason M. | Chief Executive Officer | 46,455 0.0189% | $109.02 | $5.06M | +12.37% | |
| 2024-08-19 | Sale | Mason Stephen M | CEO, GMPD Segment | 46,998 0.0192% | $109.21 | $5.13M | +12.37% | |
| 2024-08-19 | Sale | Alt Aaron E | Chief Financial Officer | 2,323 0.0009% | $108.91 | $252,998 | +12.37% | |
| 2024-08-19 | Sale | Snow Ola M | Chief Human Resources Officer | 34,647 0.0141% | $109.00 | $3.78M | +12.37% | |
| 2024-08-19 | Sale | Greene Michelle D. | Chief Information Officer | 4,000 0.0016% | $108.85 | $435,400 | +12.37% | |
| 2024-08-16 | Sale | Hollar Jason M. | Chief Executive Officer | 26,716 0.0119% | $108.87 | $2.91M | +12.27% | |
| 2024-08-16 | Sale | Snow Ola M | Chief Human Resources Officer | 3,294 0.0015% | $108.00 | $355,752 | +12.27% | |
| 2024-08-15 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 17,896 0.0078% | $106.48 | $1.91M | +14.23% | |
| 2023-11-27 | Sale | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | 36,642 0.0148% | $106.31 | $3.9M | +0.17% | |
| 2023-08-28 | Sale | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | 6,712 0.0027% | $89.81 | $602,805 | +15.39% | |
| 2023-08-18 | Sale | Scherer Mary C. | Chief Accounting Officer | 20,695 0.0082% | $86.27 | $1.79M | +19.62% | |
| 2023-08-17 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 10,668 0.0043% | $87.68 | $935,370 | +18.83% | |
| 2023-08-17 | Sale | Mason Stephen M | CEO, Medical Segment | 37,500 0.0149% | $87.32 | $3.27M | +18.83% | |
| 2023-08-17 | Sale | Snow Ola M | Chief Human Resources Officer | 26,324 0.0105% | $87.41 | $2.3M | +18.83% | |
| 2023-08-17 | Sale | Greene Michelle D. | Chief Information Officer | 2,000 0.0008% | $86.79 | $173,580 | +18.83% | |
| 2023-08-16 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 30,145 0.0119% | $90.84 | $2.74M | +13.47% | |
| 2022-11-15 | Brennan Michelle | director | 200 <0.0001% | $74.72 | $14,944 | +15.31% | ||
| 2022-11-14 | Brennan Michelle | director | 200 <0.0001% | $76.30 | $15,260 | +13.62% |
Insider Historical Profitability
| Hollar Jason M. | Chief Executive Officer | 197636 0.0828% | $30.49M | 0 | 2 | |
| Mayer Jessica L | Chief Legal/Compliance Officer | 75971 0.0318% | $11.72M | 0 | 5 | |
| Mason Stephen M | CEO, GMPD Segment | 40671 0.017% | $6.27M | 0 | 3 | |
| Alt Aaron E | Chief Financial Officer | 36867 0.0154% | $5.69M | 0 | 1 | |
| Snow Ola M | Chief Human Resources Officer | 27516 0.0115% | $4.24M | 2 | 5 | +14.84% |
| Greene Michelle D. | Chief Information Officer | 19242 0.0081% | $2.97M | 0 | 2 | |
| Scherer Mary C. | Chief Accounting Officer | 8752 0.0037% | $1.35M | 0 | 2 | |
| WALTER ROBERT D | director | 937754 0.3929% | $144.65M | 1 | 12 | +9.08% |
| WALTER MATTHEW D | director | 907663 0.3803% | $140.01M | 0 | 7 | |
| Barrett George S | Chairman and CEO | 464231 0.1945% | $71.61M | 0 | 13 | |
| Kaufmann Michael C | Chief Executive Officer | 211849 0.0888% | $32.68M | 0 | 16 | |
| CLARK R KERRY | Former Chairman and CEO | 172680 0.0723% | $26.64M | 1 | 0 | <0.0001% |
| Casey Donald M Jr. | CEO, Medical Segment | 138319 0.058% | $21.34M | 0 | 2 | |
| Morford Craig S | Chief Legal/Compliance Officer | 90811 0.038% | $14.01M | 0 | 8 | |
| Lynch Michael A | CEO, Medical Segment | 89204 0.0374% | $13.76M | 0 | 2 | |
| FORD BRENDAN A | EVP-Corporate Development | 87052 0.0365% | $13.43M | 1 | 4 | +25.14% |
| FOTIADES GEORGE L | President & COO | 80400 0.0337% | $12.4M | 6 | 2 | <0.0001% |
| Giacomin Jon L | CEO, Medical Segment | 72652 0.0304% | $11.21M | 0 | 4 | |
| Henderson Jeffrey William | Chief Financial Officer | 67190 0.0282% | $10.36M | 0 | 17 | |
| GERBIG ROBERT L | director | 66218 0.0277% | $10.21M | 0 | 1 | |
| MORRISON PATRICIA | Chief Information Officer | 36157 0.0151% | $5.58M | 0 | 3 | |
| LABRUM RONALD K | CEO-Supply Chain Svcs. | 36082 0.0151% | $5.57M | 0 | 6 | |
| NOTEBAERT RICHARD C | director | 35778 0.015% | $5.52M | 0 | 5 | |
| WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | 35202 0.0147% | $5.43M | 0 | 2 | |
| Stephen Falk T | EVP, Gen. Counsel & Corp. Sec. | 33633 0.0141% | $5.19M | 0 | 10 | |
| WATKINS CAROLE S | Chief HR Officer | 31585 0.0132% | $4.87M | 0 | 12 | |
| THOMAS STEPHEN S | EVP-Group Pres.-AIS | 31039 0.013% | $4.79M | 0 | 1 | |
| HAVENS JOHN F | director | 26034 0.0109% | $4.02M | 0 | 1 | |
| PARRISH MARK W | CEO - HSCS | 25016 0.0105% | $3.86M | 0 | 11 | |
| FINN JOHN F | director | 22957 0.0096% | $3.54M | 0 | 4 | |
| DARDEN CALVIN | director | 22771 0.0095% | $3.51M | 0 | 3 | |
| Arnold Colleen F. | director | 21597 0.009% | $3.33M | 0 | 2 | |
| Blake Mark R | EVP - Strategy & Corp. Dev. | 20409 0.0086% | $3.15M | 0 | 12 | |
| KENNY GREGORY B | director | 19584 0.0082% | $3.02M | 0 | 1 | |
| SPAULDING JEAN G | director | 17182 0.0072% | $2.65M | 1 | 6 | <0.0001% |
| COX CARRIE SMITH | director | 14129 0.0059% | $2.18M | 1 | 0 | +37.73% |
| SLUSSER ERIC | EVP, CAO & Controller | 8573 0.0036% | $1.32M | 0 | 1 | |
| LAWS STUART G | SVP & Chief Accounting Officer | 6296 0.0026% | $971,158.00 | 0 | 12 | |
| English Patricia M | Chief Accounting Officer | 6085 0.0025% | $938,611.25 | 0 | 1 | |
| Brennan Michelle | director | 3324 0.0014% | $512,727.00 | 3 | 0 | +12.78% |
| ANDERSON DAVID J | director | 3028 0.0013% | $467,069.00 | 1 | 0 | <0.0001% |
| RAISBECK DAVID W | director | 3000 0.0013% | $462,750.00 | 1 | 0 | +9.08% |
| MCCOY JOHN B | director | 958 0.0004% | $147,771.50 | 0 | 2 | |
| DAVIDS JODY R | EVP & CIO | 1000 0.0004% | $154,250.00 | 0 | 2 | |
| SCHLOTTERBECK DAVID L | Former Vice Chair & CEO CTS | 375 0.0002% | $57,843.75 | 0 | 3 | |
| JENSEN GARY S | SVP - Corporate Controller | 462 0.0002% | $71,263.50 | 0 | 2 | |
| JONES CLAYTON M | director | 0 0% | $0 | 0 | 1 | |
| KING DAVID P | director | 0 0% | $0 | 0 | 1 |
CAH Institutional Investors: Active Positions
| Increased Positions | 546 | +47.15% | 20M | +9.63% |
| Decreased Positions | 481 | -41.54% | 18M | -8.81% |
| New Positions | 160 | New | 6M | New |
| Sold Out Positions | 91 | Sold Out | 4M | Sold Out |
| Total Postitions | 1,223 | +5.61% | 209M | +0.82% |
CAH Ownership Change vs Market
Institutional Investor Ownership
| Blackrock, Inc. | $4.76M | 13.32% | 31.82M | -371,337 | -1.15% | 2025-03-31 |
| Vanguard Group Inc | $4.6M | 12.88% | 30.77M | -20,738 | -0.07% | 2024-12-31 |
| State Street Corp | $2.07M | 5.78% | 13.82M | -355,821 | -2.51% | 2024-12-31 |
| Geode Capital Management, Llc | $876,116.00 | 2.45% | 5.86M | +109,273 | +1.9% | 2024-12-31 |
| Morgan Stanley | $759,497.00 | 2.13% | 5.08M | +131,515 | +2.66% | 2024-12-31 |
| Fmr Llc | $629,264.00 | 1.76% | 4.21M | -118,741 | -2.74% | 2024-12-31 |
| Millennium Management Llc | $507,837.00 | 1.42% | 3.4M | +3M | +331.05% | 2024-12-31 |
| Citadel Advisors Llc | $477,517.00 | 1.34% | 3.19M | +2M | +91.98% | 2024-12-31 |
| Invesco Ltd. | $475,881.00 | 1.33% | 3.18M | +140,368 | +4.61% | 2024-12-31 |
| Marshall Wace, Llp | $471,279.00 | 1.32% | 3.15M | +2M | +154.62% | 2024-12-31 |